TITLE

WOLFE: STRICTER CONTROL OF DTC NEEDED

AUTHOR(S)
Dickinson, James G.
PUB. DATE
April 2002
SOURCE
Medical Marketing & Media;Apr2002, Vol. 37 Issue 4, p34
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports developments related to direct-to-consumer advertising of drugs in the U.S. as of April 2002. Increase in the direct-to-consumer promotions; Failure of Hoffmann-LaRoche Inc. to include statements of side effects on the Xeloda advertisement; Preference of drug companies to use network television for product launching.
ACCESSION #
8617704

 

Related Articles

  • Honesty is the Best Policy. Hallahan, Mary; Mordock, Jeff // Pharmaceutical Executive;Nov99, Vol. 19 Issue 11, p87 

    Provides information on the direct-to-consumer advertising for Hoffmann-La Roche's diet drug, Xenical. Budget for the campaign; Analysis of Xenical advertisements; Goal of the campaign.

  • Roche Looks for New Spin on Xenical.  // Pharmaceutical Executive;May2000, Vol. 20 Issue 5, p154 

    Announces the search of Hoffman-La Roche for an advertising agency to promote its antiobesity drug Xenical. Revenues generated by sales of the drug for the first quarter of 2000; Advertising expenditures of the company for the drug; Media buys that the company initiated.

  • Roche Kicks Off Review for Xenical. McMains, Andrew // Adweek Western Edition;04/17/2000, Vol. 50 Issue 16, p86 

    Focuses on a review of Xenical advertising account launched by pharmaceutical company Roche Laboratories in 2000. Advertising spending of the company in 1999; Factor affecting the sales of the drug; Features of the campaign.

  • NEWS IN BRIEF: NEW JERSEY.  // Advocate;3/23/93, Issue 625, p22 

    Reports that about 200 people blocked entrances at the U.S. headquarters of the Swiss pharmaceutical firm Hoffmann-La Roche Inc. in Nutley, New Jersey. Claim that the company was stalling development of a promising AIDS drug until the federal government agrees to subsidize the research.

  • Tamiflu radio ad misleading: DDMAC.  // Medical Marketing & Media;Aug2002, Vol. 37 Issue 8, p34 

    Reports that the U.S. Food and Drug Administration has ordered Hoffman-LaRoche Inc. to stop running a radio direct-to-consumer advertising for its flu drug Tamiflu.

  • Hoffman-La Roche: Employee cafeteria combines lowfat meals.  // FoodService Director;09/15/97, Vol. 10 Issue 9, p6 

    Reports why Hoffman-La Roche, the international pharmaceutical giant based in Nutley, New Jersey, is planning to offer a diet plan for its employees. Designing of breakfast and lunch menus for the diet plan; Hoffman-La Roche expecting government approval for Zencal.

  • Obesity drugs trim ads. Goetzl, David // Advertising Age;8/13/2001, Vol. 72 Issue 33, p10 

    The article reports on the decision of obesity drug manufacturers Hoffmann-La Roche and Abbott Pharmaceuticals to discontinue direct-to-consumer (DTC) advertising for their products. Hoffmann-La Roche's new campaign, launched in February 2001, which was designed in part to divert attention from...

  • Xenical account moves to Y&R.  // Medical Marketing & Media;Aug2000, Vol. 35 Issue 8, p24 

    Reports that Hoffmann-La Roche has moved its account for Xenical to Y&R Advertising. Previous handling of the account by Lowe Consumer Healthcare; Awarding of the first professional promotion for Xenical to Sudler and Hennessey.

  • Repositioning the Human Resource Function at Hoffmann-LaRoche. Rubino, Alan L. // Human Resource Planning;1994, Vol. 17 Issue 2, p45 

    This article examines the repositioning process adopted by the pharmaceutical company Hoffmann La-Roche Inc., in managing its human resources. The role of the human resource function is changing radically in leading companies, in response to new business challenges and significant opportunities...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics